| Literature DB >> 32318382 |
Abilash J Bhansali1, Leeberk R Inbaraj1,2, Carolin E George1,2, Gift Norman1,2.
Abstract
BACKGROUND: Diagnosis of urinary tract infection (UTI) can be challenging as symptoms are nonspecific. The gold standard for the diagnosis of urine culture is not easily available in resource constrained settings. Hence, the need for affordable point of care diagnostic test could be an inexpensive alternative for urine culture or microscopy. The objective of the study was to validate the urine dipstick test to detect UTI in a resource constrained primary care setting.Entities:
Keywords: Dipstick; limited resource setting; urinary tract infection
Year: 2020 PMID: 32318382 PMCID: PMC7114041 DOI: 10.4103/jfmpc.jfmpc_696_19
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Demographic character (n=136)
| Parameter | Category | Number | % |
|---|---|---|---|
| Gender | Male | 25 | 18.38 |
| Female | 111 | 81.61 | |
| Age | 18-30 | 45 | 33.09 |
| 31-50 | 66 | 48.53 | |
| 51-70 | 25 | 18.38 | |
| Diabetes status | Yes | 16 | 11.7 |
| No | 120 | 88.3 |
Distribution of symptoms
| Number | Percentage | |
|---|---|---|
| Fever | 61 | 44.85 |
| Pain while passing urine | 73 | 53.68 |
| Burning Sensation | 113 | 83.09 |
| Itching | 28 | 20.59 |
| Lower Abdomen Pain | 73 | 53.68 |
| Change in colour of urine | 68 | 50.00 |
| White Discharge | 39 | 26.68 |
Validity of diagnostic tests
| Tests | Sensitivity (95% CI) % | Specificity (95% CI)% | PPV (95% CI) % | NPV (95% CI) % | + LR | -LR |
|---|---|---|---|---|---|---|
| Nitrite | 40 (27-53) | 95 (90-99) | 84 (69-98) | 72 (63-80) | 8.4 (3.0-23.3) | 0.62 (0.49-0.78) |
| Leucocyte esterase | 65 (51-80) | 73 (64-82) | 51 (38-65) | 83 (75-91) | 2.5 (1.67-3.74) | 0.46 (0.29-0.72) |
| Combined (both positive) | 40 (27-53) | 95 (90-99) | 84 (69-98) | 72 (63-80) | 8.4 (3.0-23.3) | 0.62 (0.49-0.78) |
| Combined (Either Nitrite or Leucocyte positive) | 51 (38-65) | 83 (75-91) | 65 (51-80) | 73 (64-82) | 3.11 (1.80-5.3) | 0.57 (0.42-0.77) |
| Routine analysis | 86 (77-95) | 39 (28-49) | 46 (36-56) | 82 (70-94) | 1.4 (1.1-1.7) | 0.34 (0.16-0.71) |
Figure 1Symptom profile and validity
Validity of symptoms in detecting UTI
| Tests | Sensitivity (95% CI) % | Specificity (95% CI)% | PPV (95% CI) % | NPV (95% CI) % |
|---|---|---|---|---|
| Dysuria | 0.86 (0.77-0.95) | 0.19 (0.10-0.27) | 0.39 (0.30-0.48) | 0.69 (0.50-0.88) |
| Fever | 0.57 (0.44-0.71) | 0.63 (0.52-0.73) | 0.49 (0.36-0.61) | 0.70 (0.6-0.8) |
| Lower abdominal pain | 0.57 (0.44-0.7) | 0.54 (0.44-0.65) | 0.44 (0.32-0.55) | 0.67 (0.56-0.78) |
| Painful micturation | 0.51 (0.38-0.65) | 0.45 (0.34-0.55) | 0.36 (0.25-0.48) | 0.60 (0.48-0.72) |
| Change in colour of urine | 0.55 (0.42-0.69) | 0.47 (0.36-0.58) | 0.39 (0.28-0.50) | 0.63 (0.51-0.73) |
| Dysuria + Fever | 0.5 (0.36-0.63) | 0.69 (0.59-0.78) | 0.5 (0.36-0.63) | 0.69 (0.59-0.78) |
| Dysuria + Lower abdominal pain | 0.51 (0.38-0.65) | 0.64 (0.54-0.74) | 0.47 (0.34-0.60) | 0.68 (0.58-0.78) |
| Dysuria + Change in colour of urine | 0.46 (0.32-0.59) | 0.60 (0.50-0.71) | 0.42 (0.29-0.54) | 0.64 (0.54-0.75) |
| Fever + Lower abdominal pain | 0.30 (0.18-0.43 | 0.82 (0.73-0.90) | 0.51 (0.34-0.69) | 0.65 (0.56-0.74) |
| Diabetes + dysuria | 0.29 (0.14-0.38) | 0.76 (0.67-0.85) | 0.41 (0.24-0.57) | 0.62 (0.53-0.72) |
| Diabetes + dysuria + fever | 0.15 (0.05-0.25) | 0.92 (0.87-0.98) | 0.57 (0.31-0.83) | 0.63 (0.55-0.72) |
| Fever + dysuria + dipstick | 0.19 (0.85-0.29) | 0.98 (0.96-1.01) | 0.90 (0.73-1.07) | 0.66 (0.58-0.74) |
Antibiotic sensitivity pattern
| Susceptibility | N | AK | AMC | AMP | CEFP | CEFL | CEFR | CEFZ | CLOX | COT | CPI | CTX | ERT | GEN | IE | LEV | LIZ | MER | NIT | PITA | TCP | TETR | VA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E. Coli | 21 | 95.2 | 19 | 19 | 80.9 | 4.76 | 38 | 38 | 4.76 | 52.3 | 38 | 47.6 | 95.2 | 66.6 | 95.2 | 14.2 | 4.76 | 100 | 85.7 | 76.1 | 4.76 | 4.76 | 4.76 |
| S.aureus | 5 | 20 | 80 | 20 | 0 | 80 | 40 | 20 | 60 | 40 | 20 | 20 | 0 | 0 | 0 | 20 | 100 | 0 | 40 | 20 | 80 | 100 | 100 |
| Enterobacter | 4 | 100 | 0 | 25 | 100 | 0 | 25 | 25 | 0 | 50 | 100 | 50 | 100 | 75 | 100 | 0 | 0 | 100 | 50 | 100 | 0 | 0 | 0 |
| Klebsiella | 3 | 100 | 0 | 0 | 100 | 0 | 66.6 | 66.6 | 0 | 100 | 100 | 100 | 100 | 100 | 100 | 0 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| Enterococcus | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 0 | 100 | 0 | 0 | 0 | 0 | 0 | 100 | 100 |
| Acinetobacter | 1 | 100 | 0 | 0 | 100 | 0 | 0 | 100 | 0 | 100 | 100 | 0 | 0 | 100 | 100 | 100 | 0 | 100 | 100 | 100 | 0 | 0 | 0 |
| NFNGB | 1 | 100 | 0 | 0 | 100 | 0 | 100 | 0 | 0 | 100 | 100 | 100 | 0 | 100 | 100 | 100 | 0 | 100 | 0 | 100 | 0 | 0 | 0 |
| S.agalactae | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 100 | 0 | 0 | 0 | 0 | 100 | 100 |
AK: Amikacin; AMC: Amoxicillin Clavulanic acid; AMP: Ampicillin; CEFP: Cefaperazone; CEFL: Cefalexin; CEFR: Cefuroxime; CEFZ: Cefazolin; CLOX: Cloxacillin; COT: Cotrimoxazole; CPI: Ciprofloxacin; CTX: Ceftriaxone; ERT: Ertapenam; GEN: Gentamicin; IE: Imipenam; LEV: Levofloxacin; LIZ: Linezolid; MER: Meropenam; NIT: Nitrofurantoin; PITA: Piperacillin Tazobactum; TCP: Teicoplanin; TETR: Tetracycline; VA: Vancomycin